Filing Details
- Accession Number:
- 0001209191-21-010703
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-16 16:15:11
- Reporting Period:
- 2021-02-11
- Accepted Time:
- 2021-02-16 16:15:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1661567 | Michael Parini | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Chief Adm, Leg & Bd Off | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-02-11 | 3,818 | $210.43 | 50,846 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-02-11 | 300 | $211.21 | 50,546 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-02-11 | 200 | $211.97 | 50,346 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $210.43 (range $209.95 to $210.94).
- Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $211.21 (range $210.97 to $211.33).
- Open market sales reported on this line occurred at a weighted average price of $211.97 (range $211.97 to $211.98).